Livmed Pharmaceutical Private Limited

Livmed Pharmaceutical Private Limited

Manufactures and sells various medicines, including paracetamol, since 2020.
2020 | Cuttack, Odisha (India) | Active

Last Updated:

November 17, 2024
HomeCompanyLivmed Pharmaceutical Private Limited

Who are the key members and board of directors at Livmed Pharmaceutical?

Board Members(2)

NameDesignationAppointment DateStatus
Gorekha Sahoo In Director 19-Oct-2020Current
Himanshu Behera In Director 19-Oct-2020Current

Financial Performance of Livmed Pharmaceutical.

Livmed Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.64% increase. The company also saw a substantial improvement in profitability, with a 100.05% increase in profit. The company's net worth Soared by an impressive increase of 21.46%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
15.64%
Revenue from Operations
15.64%
Total Assets
10.51%
Profit or Loss
100.05%
Net Worth
21.46%
EBITDA
-110.94%

Charges (Loans)

Open Charges

₹0.40 M

LenderAmountStatus

Canara Bank

Creation Date: 21 Jan 2022
₹0.40 MOpen

How Many Employees Work at Livmed Pharmaceutical?

Livmed Pharmaceutical has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Livmed Pharmaceutical

Recent activity within the organization

  • Annual General Meeting

    Livmed Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Livmed Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.

    31 Mar 2023

  • Charges

    A charge with Canara Bank amounted to Rs. 0.40 M with Charge ID 100546197 was registered on 21 Jan 2022.

    21 Jan 2022

  • Director Appointment

    Gorekha Nath Sahoo was appointed as a Director was appointed as a Director on 19 Oct 2020 & has been associated with this company since 4 years 2 months .

    19 Oct 2020

  • Director Appointment

    Himanshu Behera was appointed as a Director was appointed as a Director on 19 Oct 2020 & has been associated with this company since 4 years 2 months .

    19 Oct 2020

  • Company Incorporation

    Livmed Pharmaceutical Private Limited was registered on 19 Oct 2020 with Roc Cuttack & aged 4 years 2 months as per MCA records.

    19 Oct 2020

Frequently asked questions

  • Livmed Pharmaceutical Private Limited was incorporated on 19 Oct 2020.

  • The authorized share capital of Livmed Pharmaceutical Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Livmed Pharmaceutical Private Limited.

    • Gorekha Nath Sahoo
    • Himanshu Behera
  • As per Ministry of Corporate Affairs (Mca), the registered address of Livmed Pharmaceutical Private Limited is Plot No 288 -1142 Kanheipur - Crri India, Cuttack, Orissa, 753006.

  • The corporate identification number (CIN) of Livmed Pharmaceutical Private Limited is U24239OR2020PTC034502 and the company number is 034502 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Livmed Pharmaceutical Private Limited has risen by 15.64%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Livmed Pharmaceutical Private Limited has experienced an upsurge of 21.46%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Livmed Pharmaceutical Private Limited amount to ₹ 0.40 M.

  • The most recent Balance Sheet for Livmed Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Drug Formulation & Development